Memphasys Limited (ASX:MEM)
Australia · Delayed Price · Currency is AUD 0.0040
0.00 (0.00%)
At close: Nov 6, 2026
Memphasys Market Cap
Memphasys has a market cap or net worth of 12.38 million as of November 9, 2026. It is the 42,284th most valuable company in the world and the 1,227th biggest in Australia. Its market cap has increased by 38.11% in one year.
Market Cap
12.38M
Enterprise Value
15.45M
Revenue
657.97K
Global Rank
Country Rank
#1,227 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since May 14, 2007, Memphasys's market cap has increased from 5.33M to 12.38M, an increase of 132.35%. That is a compound annual growth rate of 4.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 12.38M | -34.18% |
| Dec 31, 2025 | 18.81M | 32.77% |
| Dec 31, 2024 | 14.17M | 4.43% |
| Dec 29, 2023 | 13.57M | 1.01% |
| Dec 30, 2022 | 13.43M | -81.77% |
| Dec 31, 2021 | 73.67M | -2.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| HeraMED | 42.87M |
| Nova Eye Medical | 41.31M |
| Cleo Diagnostics | 38.39M |
| CleanSpace Holdings | 35.71M |
| Control Bionics | 26.61M |
| OncoSil Medical | 25.14M |
| Micro-X | 23.33M |
| Atomo Diagnostics | 13.54M |